Table 4.
Factors associated with PTSD: Binary analyses.
| Variable | b coefficient (SE) | P-value | Odds ratio (95% CI) |
|---|---|---|---|
| Sex, male | 0.48 (0.37) | 0.196 | 1.61 (0.78, 3.31) |
| Age (≥65) | 0.13 (0.37) | 0.731 | 1.14 (0.55, 2.37) |
| Severe COVID-19 infection | 0.53 (0.41) | 0.191 | 1.71 (0.77, 3.80) |
| Time from discharge to follow-up (≤ 180 days) | −0.69 (0.39) | 0.780 | 0.50 (0.23, 1.08) |
| Comorbidity | −0.27 (0.35) | 0.443 | 0.77 (0.39, 1.51) |
| Clinical sequelae at discharge | 0.03 (0.44) | 0.946 | 1.03 (0.44, 2.43) |
| Clinical sequelae at follow-up | |||
| General symptoms | 0.71 (0.42) | 0.094 | 2.02 (0.89, 4.61) |
| Respiratory symptoms | 1.26 (0.38) | 0.001 | 3.53 (1.68, 7.42) |
| Digestive symptoms | 0.55 (0.38) | 0.146 | 1.73 (0.83, 3.62) |
| Neurologic symptoms | −0.14 (0.47) | 0.77 | 0.87 (0.34, 2.19) |
| Anxiety | 2.68 (0.37) | <0.001 | 14.64 (7.09, 30.21) |
| Sleep difficulty | 0.78 (0.33) | 0.019 | 2.17 (1.14, 4.16) |
Bold values refer to P < 0.05.
CI, confidence interval.